Log In
Print this Print this

Feiba NF

  Manage Alerts
Collapse Summary General Information
Company Baxalta Inc.
DescriptionNano-filtered and vapor-heated sterile human plasma fraction composed of blood-clotting proteins other than Factor VIII
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsProphylactic treatment of hemophilia A and B in patients with inhibitors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today